Affiliation:
1. National Pulmonary Hypertension Service Royal Free London NHS Foundation TrustLondon United Kingdom
2. UCL Department of Cardiac MRI University College London (Royal Free Campus) London United Kingdom
3. Institute of Cardiovascular ScienceUniversity College London United Kingdom
4. Department of Respiratory Medicine Royal Free London NHS Foundation TrustLondon United Kingdom
5. National Amyloidosis Centre Division of Medicine University College London United Kingdom
6. Department of Cardiology Royal Free London NHS Foundation TrustLondon United Kingdom
Abstract
Background
Ongoing exercise intolerance of unclear cause following COVID‐19 infection is well recognized but poorly understood. We investigated exercise capacity in patients previously hospitalized with COVID‐19 with and without self‐reported exercise intolerance using magnetic resonance–augmented cardiopulmonary exercise testing.
Methods and Results
Sixty subjects were enrolled in this single‐center prospective observational case‐control study, split into 3 equally sized groups: 2 groups of age‐, sex‐, and comorbidity‐matched previously hospitalized patients following COVID‐19 without clearly identifiable postviral complications and with either self‐reported reduced (COVID
reduced
) or fully recovered (COVID
normal
) exercise capacity; a group of age‐ and sex‐matched healthy controls. The COVID
reduced
group had the lowest peak workload (79W [Interquartile range (IQR), 65–100] versus controls 104W [IQR, 86–148];
P
=0.01) and shortest exercise duration (13.3±2.8 minutes versus controls 16.6±3.5 minutes;
P
=0.008), with no differences in these parameters between COVID
normal
patients and controls. The COVID
reduced
group had: (1) the lowest peak indexed oxygen uptake (14.9 mL/minper kg [IQR, 13.1–16.2]) versus controls (22.3 mL/min per kg [IQR, 16.9–27.6];
P
=0.003) and COVID
normal
patients (19.1 mL/min per kg [IQR, 15.4–23.7];
P
=0.04); (2) the lowest peak indexed cardiac output (4.7±1.2 L/min per m
2
) versus controls (6.0±1.2 L/min per m
2
;
P
=0.004) and COVID
normal
patients (5.7±1.5 L/min per m
2
;
P
=0.02), associated with lower indexed stroke volume (SVi:COVID
reduced
39±10 mL/min per m
2
versus COVID
normal
43±7 mL/min per m
2
versus controls 48±10 mL/min per m
2
;
P
=0.02). There were no differences in peak tissue oxygen extraction or biventricular ejection fractions between groups. There were no associations between COVID‐19 illness severity and peak magnetic resonance–augmented cardiopulmonary exercise testing metrics. Peak indexed oxygen uptake, indexed cardiac output, and indexed stroke volume all correlated with duration from discharge to magnetic resonance–augmented cardiopulmonary exercise testing (
P
<0.05).
Conclusions
Magnetic resonance–augmented cardiopulmonary exercise testing suggests failure to augment stroke volume as a potential mechanism of exercise intolerance in previously hospitalized patients with COVID‐19. This is unrelated to disease severity and, reassuringly, improves with time from acute illness.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献